ERICA ERB: Open Payments
NPI 1801943303 · HILLSBOROUGH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 51 payments from 14 companies in 2025. Trend: 2023 $180 · 2024 $928 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $171 |
| PFIZER INC. | 7 | $119 |
| ABBVIE INC. | 7 | $116 |
| Lilly USA, LLC | 6 | $97 |
| AstraZeneca Pharmaceuticals LP | 6 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| Exact Sciences Corporation | 2 | $54 |
| Amgen Inc. | 2 | $36 |
| IBSA Pharma Inc. | 1 | $18 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18 |
Products named: Wegovy, CAPLYTA, MOUNJARO, QULIPTA, ELIQUIS, FARXIGA, NURTEC ODT, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
